On April 1, 2020, the FDA announced a recall of ranitidine, also known as Zantac, a common medication used to treat reflux in adults and children. Removing this medication from shelves and urging all users to dispose of the drug and cease taking it comes after months of warnings and increasing concern about the potential dangers of a suspected carcinogen NDMA (N-Nitrosodimethylamine). Research concluded that the levels of NDMA were above what is considered to be safe. Warmer storage temperatures of ranitidine containing products, like Zantac, can lead to an increase in concentrations of this suspected carcinogen. Levels were also seen to increase with time, meaning the longer the product was on the shelf, or say in your medicine cabinet, the higher the dangerous NDMA levels could climb. With all of this in the news, many GERD sufferers are exploring their options without ranitidine.
Most of us have a basic understanding that there is an appropriate time to go to the emergency room and when that time comes, we go without hesitation. However, as it has with just about everything in our lives, the COVID-19 crisis has the potential to change our health behaviors in a very serious, and quite frankly, dangerous way. One of the consequences of constant COVID-19 crisis coverage may be that many people believe that hospitals are (or soon will be) completely overrun and that they have become a breeding ground for the virus – in other words: avoid at all costs. That’s far from the truth.
The number of pre-diabetic and diabetic patients has increased dramatically over the past few decades. Today about 13% of the US population over 18 has diagnosed or undiagnosed diabetes. The primary reason for this has been an exceptional growth in obesity. While we typically discuss diabetes as a significant risk factor for a number of long-term and chronic diseases including cardiovascular disease, now, more than ever the effect diabetes has on the immune system needs to be emphasized.